"Overall, our data perpetuate the safety concerns surrounding the incretin-based therapies, but maybe the most interesting finding is that, reassuringly, while tirzepatide displays an unprecedented glucose- and weight-lowering efficacy, it comes with a similar or even improved safety profile vs GLP-1 receptor agonists," said first author Irene Caruso, MD, PhD, of the Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy, while presenting the research at the European Association for the Study of Diabetes (EASD) 2024 Annual Meeting
We spent significant time researching GLP-1 medications in-depth and developing a comprehensive policy and procedure that outlines our clinical protocol, says Jessica Huggins, Certified Medical Assistant and esthetician based at the companys Palo Alto location
After multiple attempts to get her insurance company to cover the drug (shed been prescribed it for weight management but her insurer said the drug was too new to cover), she had to stop taking it
TB-500 is researched for its actin-binding properties and effects on cellular motility in laboratory settings
CAPOX, capecitabine + oxaliplatin
Rapid weight loss itself causes telogen effluvium, temporary hair shedding that resolves after weight stabilizes